SIREN : 530562339
SARTHE MEDICAL FINANCE is a French company founded 15 years ago, specialized in the sector Activités des sociétés holding. Based in AUVERS-LE-HAMON (72300), this company of category PME shows in 2025 a revenue of 62 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Kennzahl | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Umsatz | 62 500 € | 130 000 € | 194 400 € | 194 400 € | 194 000 € | 160 000 € | 154 750 € | 147 000 € | 147 000 € |
| Nettoergebnis | -108 018 € | 1 132 € | 28 498 € | 25 267 € | 18 778 € | 47 068 € | 4 273 € | 41 790 € | 49 212 € |
| EBITDA | -66 889 € | 4 059 € | 11 322 € | 21 699 € | 784 € | 4 958 € | 4 539 € | 2 272 € | 10 554 € |
| Nettomarge | -172.8% | 0.9% | 14.7% | 13.0% | 9.7% | 29.4% | 2.8% | 28.4% | 33.5% |
In 2025, SARTHE MEDICAL FINANCE achieves revenue of 62 k€. Revenue is declining over the period 2016-2025 (CAGR: -9.1%). Significant drop of -52% vs 2024. After deducting consumption (0 €), gross margin stands at 62 k€, i.e. a rate of 100%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -67 k€, representing -107.0% of revenue. Warning negative scissor effect: despite revenue change (-52%), EBITDA varies by -1748%, reducing margin by 110.1 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Net income is negative at -108 k€ (-172.8% of revenue), which will impact equity.
62 500 €
62 500 €
-66 889 €
-67 198 €
-108 018 €
-107.0%
The debt ratio (= Financial debt / Equity x 100) stands at 8%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 91%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
7.906%
90.675%
-108.334%
-0.381
69.5%
In 2025, the debt ratio of SARTHE MEDICAL FINANCE (7.91) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
In 2025, the financial autonomy of SARTHE MEDICAL FINANCE (90.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
In 2025, the repayment capacity of SARTHE MEDICAL FINANCE (-0.38) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
The liquidity ratio (= Current assets / Current liabilities) stands at 1376.32. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
1376.321
-2.615
In 2025, the liquidity ratio of SARTHE MEDICAL FINANCE (1376.32) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2025, the interest coverage of SARTHE MEDICAL FINANCE (-2.6x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 11 days. Favorable situation: supplier credit is longer than customer credit by 11 days. WCR is negative (-8 days): operations structurally generate cash. Notable WCR improvement over the period (-108%), freeing up cash.
-1 437 €
0 j
11 j
0 j
-8 j
Indicative estimate only : the number of comparable transactions in this sector is limited (20 transactions). This range of 30 607€ to 78 263€ is provided for information purposes only and requires in-depth analysis to be confirmed.
This estimate is based on the analysis of 20 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare SARTHE MEDICAL FINANCE with other companies in the same sector:
Voir toutes les statistiques du secteur Activités des sociétés holding
The revenue of SARTHE MEDICAL FINANCE in 2025 is 62 k€.
SARTHE MEDICAL FINANCE recorded a net loss in 2025.
The headquarters of SARTHE MEDICAL FINANCE is located in AUVERS-LE-HAMON (72300), in the department Sarthe.
The tax return of SARTHE MEDICAL FINANCE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
SARTHE MEDICAL FINANCE operates in the sector Activités des sociétés holding (NAF code 64.20Z). See the 'Sector positioning' section above to compare the company with its competitors.